VIA
WVE icon

Virtus Investment Advisers’s Wave Life Sciences WVE Stock Holding History

Virtus Investment Advisers’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$324K Buy
55,741
+39,276
+239% +$260K 0.08% 362
2026
Q1 		$119K Buy
16,465
+401
+2% +$5.22K 0.03% 447
2025
Q4 		$273K Buy
16,064
+260
+2% +$2.64K 0.07% 284
2025
Q3 		$116K Buy
15,804
+2,744
+21% +$22.2K 0.03% 409
2025
Q2 		$84.9K Buy
13,060
+1,210
+10% +$7.99K 0.03% 404
2025
Q1 		$95.7K Buy
+11,850
New +$130K 0.03% 426

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Virtus Investment Advisers's WVE Position: Q2 2026 in Review

Virtus Investment Advisers increased its Wave Life Sciences (WVE) stake by 239% in Q2 2026, buying an estimated $260K and bringing the position to 55,741 shares worth $324K. The position accounts for 0.08% of the portfolio, ranked #362.

Virtus Investment Advisers first reported a position in WVE in Q1 2025 and has held it in 6 quarters since. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Virtus Investment Advisers held 55,741 shares of Wave Life Sciences worth $324K as of Q2 2026.
  • Virtus Investment Advisers bought 39,276 Wave Life Sciences shares in Q2 2026, an estimated $260K.
  • Wave Life Sciences made up 0.08% of Virtus Investment Advisers's portfolio in Q2 2026, its #362 holding.
  • Virtus Investment Advisers first reported a position in Wave Life Sciences in Q1 2025 and has held it in 6 quarters since.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Virtus Investment Advisers's 13F filing for Q2 2026, filed 11 Aug 2026.